Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Cancer Letters|February 16, 2010
MYCN oncoprotein targets and their therapeutic potentialEmma Bell, Lindi Chen, Tao Liu, et al.
International Journal of Oncology|November 24, 2011
Recombinant human MDM2 oncoprotein shows sequence composition selectivity for binding to both RNA and DNAChristine Challen, John J Anderson, Zofia M A Chrzanowska-Lightowlers, et al.
The Prostate|April 19, 2007
Analysis of the MDM2 antagonist nutlin-3 in human prostate cancer cellsIan R Logan, Hesta V McNeill, Susan Cook, et al.
Hybridoma (2005)|December 23, 2009
A monoclonal antibody for detection of folylpolyglutamate synthetase in paraffin embedded tissuesAmy E Quinn, Michael Pinkney, Nigel H Piggott, et al.
International Journal of Molecular Sciences|July 29, 2023
<i>SF3B1</i> Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic LeukemiaErhan Aptullahoglu, Jonathan P Wallis, Helen Marr, et al.
Hybridoma (2005)|November 6, 2007
A novel monoclonal antibody for detection of folate receptor alpha in paraffin-embedded tissuesAmy E Smith, Michael Pinkney, Nigel H Piggott, et al.
Cancers|December 23, 2018
ATM Dependent DUSP6 Modulation of p53 Involved in Synergistic Targeting of MAPK and p53 Pathways with Trametinib and MDM2 Inhibitors in Cutaneous MelanomaChiao-En Wu, Tsin Shue Koay, Arman Esfandiari, et al.
Clinical & Experimental Metastasis|May 27, 2014
COX2 expression in neuroblastoma increases tumorigenicity but does not affect cell death in response to the COX2 inhibitor celecoxibEmma Bell, Frida Ponthan, Claire Whitworth, et al.
Biomedicines|July 27, 2024
RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in <i>TP53</i> Wild-Type Chronic Lymphocytic LeukemiaErhan Aptullahoglu, Sirintra Nakjang, Jonathan P Wallis, et al.
International Journal of Oncology|February 3, 2018
Characterisation of the p53 pathway in cell lines established from TH-MYCN transgenic mouse tumoursLindi Chen, Arman Esfandiari, William Reaves, et al.
Pageof 8